- Home
- GILD vs C Comparison
GILD vs C Comparison
Compare GILD & C Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- C
- Stock Information
- Founded
- GILD 1987
- C 1812
- Country
- GILD United States
- C United States
- Employees
- GILD N/A
- C N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- C Major Banks
- Sector
- GILD Health Care
- C Finance
- Exchange
- GILD Nasdaq
- C Nasdaq
- Market Cap
- GILD 131.5B
- C 127.5B
- IPO Year
- GILD 1992
- C N/A
- Fundamental
- Price
- GILD $104.54
- C $63.25
- Analyst Decision
- GILD Buy
- C Buy
- Analyst Count
- GILD 27
- C 14
- Target Price
- GILD $105.32
- C $86.89
- AVG Volume (30 Days)
- GILD 10.4M
- C 23.2M
- Earning Date
- GILD 04-24-2025
- C 04-15-2025
- Dividend Yield
- GILD 3.02%
- C 3.61%
- EPS Growth
- GILD N/A
- C 85.23
- EPS
- GILD 0.38
- C 6.33
- Revenue
- GILD $28,754,000,000.00
- C $71,819,000,000.00
- Revenue This Year
- GILD $1.80
- C $19.47
- Revenue Next Year
- GILD $3.83
- C $3.41
- P/E Ratio
- GILD $275.11
- C $9.99
- Revenue Growth
- GILD 6.04
- C 3.25
- 52 Week Low
- GILD $62.07
- C $53.51
- 52 Week High
- GILD $119.96
- C $84.74
- Technical
- Relative Strength Index (RSI)
- GILD 43.51
- C 42.25
- Support Level
- GILD $97.32
- C $61.30
- Resistance Level
- GILD $107.18
- C $66.29
- Average True Range (ATR)
- GILD 3.94
- C 3.56
- MACD
- GILD -0.45
- C 0.12
- Stochastic Oscillator
- GILD 41.42
- C 47.05
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
About C Citigroup Inc.
Citigroup is a global financial-services company doing business in more than 100 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.